The 2012 Schizophrenia International Research Society (SIRS) Conference, held in Florence, Italy, attracted more than 1,600 attendees from 53 countries to the stately Firenze Fiera Conference Center from April 14-18, 2012. Providing four major plenary sessions, thirty-five symposia sessions and six workshops, this 3rd Biennial SIRS Conference was jointly sponsored by Vanderbilt University School of Medicine, Department of Psychiatry and SIRS. In conjunction with the Schizophrenia Research Forum, a Web project of the Brain and Behavior Research Foundation, and with our thanks to the SIRS organizers and staff, we bring you the following report on the meeting's discussions concerning drug therapy development for schizophrenia, psychological and social treatment for schizophrenia, and the challenges of predicting psychosis with brain imaging.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3371/CSRP.6.2.2 | DOI Listing |
Alzheimers Res Ther
January 2025
Department of Epidemiology and Healthcare Atlas, Central Research Institute of Ambulatory Health Care in Germany, Berlin, Germany.
Background: Many risk factors for dementia have been identified, but the timing of risk is less well understood. Here, we analyzed risk factors in a case-control study covering 10 years before an incident dementia diagnosis.
Methods: We designed a case-control study using insurance claims of outpatient consultations of patients with German statutory health insurance between January 1, 2012, and December 31, 2022.
Health Place
November 2024
Department of Public Health and Exercise Science, Leon Levine Hall of Health Sciences, 1179 State Farm Rd, Appalachian State University, Boone, NC 28607, USA.
Mental health continues to be a growing crisis for children, adolescents, and young adults. Yet, increasing trends in subgroups are not uniform, and key differences exist across geographic, racial, and age groups. Few studies examine structural factors like economic and racial inequality, important upstream structural inequities that impact mental health.
View Article and Find Full Text PDFJAMA Netw Open
November 2024
Faculté de Pharmacie, Université Laval, Québec City, Québec, Canada.
Importance: The use of antipsychotics, antidepressants, and benzodiazepines may influence the risk of mortality in people with schizophrenia. However, many observational studies have not accounted for immortal time bias (ITB), which occurs when there is a period during which patients in the exposed group are necessarily alive and misclassified as exposed (the period between start of follow-up and initiation of drug). Ignoring ITB may lead to misinterpretation of the association between these drugs and mortality.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!